Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ISAR-DAPT: 3 vs 6 months dual antiplatelet therapy after Coroflex ISAR stent implantation
KCT0003736Phase 4Completed
- Sponsor
- B. Braun
- Start
- Mar 2015
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 4 trial of aspirin + P2Y12 antagonist in coronary arteriosclerosis, sponsored by B. Braun. Started Mar 2015; status: completed.
02
Drugs
aspirin + P2Y12 antagonist
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on KCT0003736.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0003736.